A phase 3 study evaluating the safety and efficacy of relugolix (Myovant Sciences), an investigational oral gonadotropin-releasing hormone (GnRH) receptor antagonist, in combination with estradiol 1.0mg and norethindrone 0.5mg in women with uterine fibroids, met its primary endpoint.
Researchers investigated the long-term risk for stroke in women with prior history of hypertensive disorders during pregnancy.
Anemia in pregnancy is associated with obstetric and maternal complications, as well as a higher risk for preterm birth for the infant.
Agency considering new patient warnings and checklists for the implants.
Participants indicated that the main reason they discontinued breastfeeding was the restart of their medication.
A new clinical guideline on the diagnosis and treatment of recurrent urinary tract infections in women was released by the AUA together with the Canadian Urological Association, and the Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction.
Antibiotic prophylaxis did not significantly lower the risk of pelvic infection in low- and middle-income countries when administered before miscarriage surgery.
Vast majority of cervical precancer cases attributable to HPV types targeted by 9-valent HPV vaccine
The USPSTF concluded that the current evidence is insufficient to assess the balance of benefits and harms of screening for elevated blood lead levels in asymptomatic children and pregnant women.
A meta-analysis showed that abaloparatide treatment reduces the risk for vertebral, nonvertebral, and wrist fractures in postmenopausal women with osteoporosis compared with placebo or other medical treatments.
